ASCO 2016 | Targeted therapy for advanced solid tumors based on molecular profiles: early results from MyPathway

Press brief by John Hainsworth, MD of the Sarah Cannon Research Institute, Nashville, TN, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.